Unveiling hidden outcomes in malignant gastric outlet obstruction research - insights from a "Pancreas 2000" review.

IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY
Filipe Vilas-Boas, Giacomo Emanuele Maria Rizzo, Charles De Ponthaud, Stuart Robinson, Sebastien Gaujoux, Gabriele Capurso, Giuseppe Vanella, Bahadır Bozkırlı
{"title":"Unveiling hidden outcomes in malignant gastric outlet obstruction research - insights from a \"Pancreas 2000\" review.","authors":"Filipe Vilas-Boas, Giacomo Emanuele Maria Rizzo, Charles De Ponthaud, Stuart Robinson, Sebastien Gaujoux, Gabriele Capurso, Giuseppe Vanella, Bahadır Bozkırlı","doi":"10.4253/wjge.v16.i8.451","DOIUrl":null,"url":null,"abstract":"<p><p>Malignant gastric outlet obstruction (mGOO) is a major condition affecting patients with periampullary tumors, including pancreatic cancer. The current treatment options include surgical gastroenterostomy, endoscopic stenting and more recently EUS-guided gastroenterostomy. Most studies comparing the outcomes of the three procedures focus on technical success, clinical success and safety. Several \"occult\" outcomes relevant to the patient's viewpoints and perspective may ultimately impact on cancer-related and overall survival, such as body mass composition, nutritional biomarkers, chemotherapy tolerance and patient-reported quality of life. The aim of this review is to provide an overview of potential key outcomes that should be explored in future comparative research around mGOO treatment options.</p>","PeriodicalId":23953,"journal":{"name":"World Journal of Gastrointestinal Endoscopy","volume":"16 8","pages":"451-461"},"PeriodicalIF":1.4000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325868/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastrointestinal Endoscopy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4253/wjge.v16.i8.451","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Malignant gastric outlet obstruction (mGOO) is a major condition affecting patients with periampullary tumors, including pancreatic cancer. The current treatment options include surgical gastroenterostomy, endoscopic stenting and more recently EUS-guided gastroenterostomy. Most studies comparing the outcomes of the three procedures focus on technical success, clinical success and safety. Several "occult" outcomes relevant to the patient's viewpoints and perspective may ultimately impact on cancer-related and overall survival, such as body mass composition, nutritional biomarkers, chemotherapy tolerance and patient-reported quality of life. The aim of this review is to provide an overview of potential key outcomes that should be explored in future comparative research around mGOO treatment options.

揭示恶性胃出口梗阻研究中的隐性成果--从 "胰腺 2000 "回顾中获得的启示。
恶性胃出口梗阻(mGOO)是影响胰腺周围肿瘤(包括胰腺癌)患者的主要疾病。目前的治疗方法包括外科胃肠造口术、内镜下支架植入术以及最近的 EUS 引导下胃肠造口术。大多数比较这三种手术效果的研究都侧重于技术成功率、临床成功率和安全性。一些与患者观点和视角相关的 "隐性 "结果可能会最终影响癌症相关和整体生存,如体质量组成、营养生物标志物、化疗耐受性和患者报告的生活质量。本综述旨在概述在未来围绕 mGOO 治疗方案的比较研究中应探索的潜在关键结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Gastrointestinal Endoscopy
World Journal of Gastrointestinal Endoscopy GASTROENTEROLOGY & HEPATOLOGY-
自引率
5.00%
发文量
1164
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信